Various respiratory pathogens like flu, mycoplasma, RSV, adenovirus and Covid-19 have become prevalent at the same time this winter, threatening the vulnerable people, and causing disruptions in daily life. Rapid and accurate identification of the infectious pathogens enables etiological treatment for patients and provides information on infection prevention and control strategies for public health facilities.
Macro & Micro-Test (MMT) has launched Multiplex Respiratory Pathogens Detection Panel , aiming to provide a rapid and effective Screening + Typing detection solution for timely diagnosis, surveillance and prevention of respiratory pathogens for clinics and public health.
The Screening Solution targeting 14 Respiratory Pathogens
Covid-19, flu A, flu B, adenovirus, RSV, parainfluenza virus, human metapneumovirus, rhinovirus, coronavirus, bocavirus, enterovirus, mycoplasma pneumoniae, Chlamydia pneumoniae, Streptococcus pneumoniae.
Screening Solution for 14 Respiratory Pathogens
The Typing Solution targeting 15 Upper Respiratory Pathogens
Flu A H1N1 (2009), H1, H3, H5, H7, H9, H10; Flu B BV, BY; Coronavirus 229E, OC43, NL63, HKU1, SARS, MERS.
Typing Solution for 15 Respiratory Pathogens
The Screening Solution and Typing Solution can be either used in combination or separately, and they are also compatible with screening kits from counterparts for flexible combined use to customers’ needs.
The Screening and Typing Solutions assisting early differential diagnosis and epidemic surveillance of respiratory tract infections shall ensure precise treatment and prevention against mass transmission.
Testing Procedure & Product Features
Option 1: With Eudemon™AIO800 (Fully Automatic Molecular Amplification System) independently developed by MMT
Advantages:
1) Easy Operation: Sample In & Result Out. Only add the collected clinical samples manually and the entire testing process shall be completed automatically by the System;
2) Efficiency: Integrated sample processing and rapid RT-PCR reaction system enable the entire testing process to be completed within 1 hour, facilitating timely treatment and reducing transmission risk;
3) Economy: Multiplex PCR technology + reagent master mix technology reduce the cost and improve sample utilization, making it more cost effective compared with similar molecular POCT solutions;
4) High Sensitivity & Specificity: Multiple LoD up to 200 copies/mL and high specificity ensure the testing accuracy and reduce false diagnosis or missed diagnosis.
5) Wide coverage: Common clinical acute respiratory tract infection pathogens covered, accounting for 95% of the pathogens in common acute respiratory infection cases according the previous studies.
Option 2: Conventional Molecular Solution
Advantages:
1) Compatibility: Widely compatible with mainstream PCR instruments on the market;
2) Efficiency: Entire process completed within 1 hour, facilitating timely treatment and reducing the transmission risk;
3) High Sensitivity & Specificity: Multiple LoD up to 200 copies/mL and high specificity ensure the testing accuracy and reduce false diagnosis or missed diagnosis.
4) Wide coverage: Common clinical acute respiratory tract infection pathogens covered, which occupying 95% of the pathogens in common acute respiratory infection cases according the previous studies.
5) Flexibility: Screening solution and typing solution can be used in combination or separately, and they are also compatible with screening kits from similar manufacturers for flexible combined use to customers’ needs.
Products information
|
Product Code |
Product Name |
Sample Types |
|
HWTS-RT159A |
14 Types of Respiratory Pathogens Combined Detection Kit (Fluorescence PCR) |
Oropharyngeal/ nasopharyngeal swab |
|
HWTS-RT160A |
29 Types of Respiratory Pathogens Combined Detection Kit (Fluorescence PCR) |
Post time: Dec-29-2023